Search

everythinglearnresearchcommunity

for

Search:↓

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The hexosamine pathway helps maintain healthy skin by affecting the skin's structure and possibly increasing hair follicle stem cells.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

Chemotherapy caused the patient's hair to have alternating thick and thin segments.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Early and accurate diagnosis of congenital smooth muscle hamartomas is crucial to distinguish them from other conditions.

The man has a genetic skin condition called pachyonychia congenita.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

A gene mutation in mice causes skin defects and early death.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

A genetic marker linked to a type of hair loss was found in most patients studied.

A new mutation in the Hairless gene causes hair loss in two Pakistani families.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Experts recommend using PN-HPT™ for skin rejuvenation in various body areas but have less agreement on initial facial treatment cycles.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

A new method accurately measures a drug in skin for cancer therapy research.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.